Company Overview and News

 
Watch out as even Fed doves fret about markets living in La-La Land - MarketWatch

14h marketwatch
The stock market just might rack up its second weekly win in a row, depending on how today’s earnings-driven trading shakes out.
Upvote Downvote

 
The new Alberta alienation: Resenting East and West

2018-04-19 cbc.ca
There was a popular joke on the playgrounds of Alberta elementary schools back in the early 1980s.
Upvote Downvote

 
Beijing Unsure How To Lobby DC; "Wei" In Weibo Rhymes With Gay; China Pushing EU Splittism?; National Security Day, There is A Party In Your Boardroom

2018-04-16 nb.sinocism
Happy Monday. This story from Tom Mitchell of the Financial Times stood out--China’s Xi Jinping says he is opposed to life-long rule - FT $$:
Upvote Downvote

 
Nasdaq Completes Sale of its Public Relations Solutions and Digital Media Services Businesses to West Corporation

2018-04-16 globenewswire
NEW YORK, April 16, 2018 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq:NDAQ) (“Nasdaq”) today announced the successful completion of the sale of its Public Relations Solutions and Digital Media Services businesses to West Corporation (“West”), a global leader in technology-enabled services, for approximately $335 million.
Upvote Downvote

 
West Corporation Closes Landmark Acquisition of Nasdaq’s Public Relations and Digital Media Businesses

2018-04-16 globenewswire
OMAHA, Neb., April 16, 2018 (GLOBE NEWSWIRE) -- West Corporation (“West” or the “Company”), a global leader in technology-enabled services, announced today it has completed the acquisition of the public relations and digital media businesses (“Public Relations Solutions and Digital Media Services”) from Nasdaq (Nasdaq:NDAQ) for approximately $335 million.
Upvote Downvote

 
Former Australian editor Chris Mitchell calls it quits on fintech start-up

2018-04-15 theage.com.au
It sounds like the start of a bad joke: a former television executive, a former editor-in-chief and a former bank boss walk into a fintech startup.
Upvote Downvote

 
Former Australian editor Chris Mitchell calls it quits on fintech start-up

2018-04-15 smh.com.au
It sounds like the start of a bad joke: a former television executive, a former editor-in-chief and a former bank boss walk into a fintech startup.
Upvote Downvote

 
Former Australian editor Chris Mitchell calls it quits on fintech startup

2018-04-15 theage.com.au
It sounds like the start of a bad joke: a former television executive, a former editor-in-chief and a former bank boss walk into a fintech startup.
Upvote Downvote

 
Former Australian editor Chris Mitchell calls it quits on fintech startup

2018-04-15 smh.com.au
It sounds like the start of a bad joke: a former television executive, a former editor-in-chief and a former bank boss walk into a fintech startup.
Upvote Downvote

 
Flash - Syria strikes punitive but not game-changing - France 24

2018-04-15 france24
Western powers have carried out their biggest attack yet against the Syrian regime but analysts say the strikes were a mostly "punitive" measure that will not change the course of the conflict.
Upvote Downvote

 
Certain of gas attack, allies struck Syria before UN report

2018-04-15 newsinfo.inquirer.net
In this photo released by the Syrian official news agency SANA, shows Syrian police units entering the town of Douma, site of a suspected chemical weapons attack and the last rebel town in the eastern Ghouta, near Damascus, Syria, Saturday, April 14, 2018. The entry of government forces to Douma follows a Russian-mediated deal that secured the surrender and evacuation of the rebels and thousands of civilians from the town.
Upvote Downvote

 
US, France, Britain launch new UN bid for Syria chemical weapons probe

2018-04-15 yahoo
United Nations (United States) (AFP) - The United States, France and Britain on Saturday launched a new bid at the United Nations to investigate chemical weapons attacks in Syria, just hours after firing military strikes against Syrian targets.
Upvote Downvote

 
Canberra Times Letters to the Editor: China’s base move poses question

2018-04-13 smh.com.au
Perhaps China is motivated to put a military base on Vanuatu to counter the US forward base at Darwin, presumably aimed at possible conflict with our major trading partner.
Upvote Downvote

 
Peter Thonemann, Australian fusion pioneer

2018-04-11 smh.com.au
Australian-born physicist Peter Thonemann was leader of the ZETA (Zero Energy Thermonuclear Assembly) project in the UK at the time of the declassification of controlled nuclear fusion research by the UK, USA and USSR in 1958.
Upvote Downvote

 
Turkey: Erdogan lashes out at France warning of ‘more terror attacks’ | Euronews

2018-04-07 euronews
Recep Tayyip Erdogan has hit out at the French government for “providing support to terrorism”, and appeared to refer to Saturday’s vehicle attack in Germany by warning “the same will happen in France”.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 952355204